课题基金 / 基金详情

SIV VACCINES PROTECT INFANT RHESUS MACAQUES AGAINST ORAL SIVEXPOSURE

SIV VACCINES PROTECT INFANT RHESUS MACAQUES AGAINST ORAL SIVEXPOSURE
SIV 疫苗可保护幼年恒河猴免受口服 SIV 暴露
批准号：
7349634
负责人：
Marta L Marthas
金额：
$15.67万
依托单位：
UNIVERSITY OF CALIFORNIA AT DAVIS
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-05-01 至 2007-04-30
来源：
https://reporter.nih.gov/project-details/7349634
关键词：
SIVVACCINESPROTECTINFANTRHESUS

项目摘要

项目成果

Marta L Marthas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objective: Ideally, a neonatal HIV vaccine aimed to prevent HIV transmission from breastfeeding would also protect against later sexual exposure to HIV in adolescence. To test HIV vaccine candidates, we developed an infant rhesus macaque model to better mimic repeated oral HIV exposure during breast-feed
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REPLICATING VIRAL VECTOR AS NEONATAL VACCINE TO PREVENT ORAL SIV TRANSMISSION
REPLICATING VIRAL VECTOR AS NEONATAL VACCINE TO PREVENT ORAL SIV TRANSMISSION
VACCINE-ELICITED ANTIBODY DEPENDENT CELL CYTOTOXICITY IN PROTECTION AGAINST SIV
REPLICATING VIRAL VECTOR AS NEONATAL VACCINE TO PREVENT ORAL SIV TRANSMISSION
海外基金